The myotonic dystrophies

Seminars in Neurology

Volumn 19, Issue 1, 1999, Pages 25-33

  Thornton, Charles ^a,b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Myotonia; Myotonic dystrophy; Myotonic myopathy; Trinucleotide repeat

Indexed keywords

DNA; HUMAN GROWTH HORMONE; METHYLPHENIDATE; MEXILETINE; PHENYTOIN; PRASTERONE SULFATE; RECOMBINANT SOMATOMEDIN C; TESTOSTERONE; TRINUCLEOTIDE;

ADULT; ARTIFICIAL VENTILATION; CATARACT; CHROMOSOME 19; CHROMOSOME 3; CLINICAL FEATURE; HEART BLOCK; HUMAN; HYPERSOMNIA; HYPOVENTILATION; INTRAVENOUS DRUG ADMINISTRATION; MUSCLE ATROPHY; MUTATION; MYOTONIA; MYOTONIC DYSTROPHY; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TRINUCLEOTIDE REPEAT;

EID: 0033023961     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1040823     Document Type: Review

References (81)

1. Harley HG, Brook JD, Rundle SA, et al. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 1992;355:545-546
2. Buxton J, Shelbourne P, Davies J, et al. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 1992;355:547-548
3. Mahadevan M, Tsilfidis C, Sabourin L, et al. Myotonic dystrophy mutation: An unstable CTG repeat in the 3′ untranslated region of the gene. Science 1992;255:1253-1255
4. Fu YH, Pizzuti A, Fenwick RG Jr, et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992;255:1256-1258
5. Morgenlander JC, Massey JM. Myotonic dystrophy. Semin Neurol 1991;11:236-243
6. Howeler CJ, Busch HF, Geraedts JP, et al. Anticipation in myotonic dystrophy: Fact or fiction? Brain 1989;112:779-797
7. Harper PS, Harley HG, Reardon W, et al. Anticipation in myotonic dystrophy: New light on an old problem. Am J Hum Genetics 1992;51:10-16
8. Redman JB, Fenwick RGJ, Fu YH, et al. Relationship between parental trinucleotide GCT repeat length and severity of myotonic dystrophy in offspring. JAMA 1993;269:1960-1965
9. Hunter A, Tsilfidis C, Mettler G, et al. The correlation of age of onset with CTG trinucleotide repeat amplification in myotonic dystrophy. J Med Genet 1992;29:774-779
10. n trinucleotide repeats. Am J Med Genet 1996;65:342-347
11. Chang L, Ernst T, Osborn D, et al. Proton spectroscopy in myotonic dystrophy - correlations with CTG repeats. Arch Neurol 1998;55:305-311
12. Brook JD, McCurrach ME, Harley HG, et al. Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′end of a transcript encoding a protein kinase family member. Cell 1992;68:799-808
13. Deka R, Majumder PP, Shriver MD, et al. Distribution and evolution of CTG repeats at the myotonin protein kinase gene in human populations. Genome Res 1996;6:142-154
14. Carey N, Johnson K, Nokelainen P, et al. Meiotic drive at the myotonic dystrophy locus? [letter]. Nature Genet 1994;6:117-118
15. Imbert G, Kretz C, Johnson K, et al. Origin of the expansion mutation in myotonic dystrophy. Nature Genet 1993;4:72-76
16. Barcelo JM, Mahadevan MS, Tsilfidis C, et al. Intergenerational stability of the myotonic dystrophy protomutation. Hum Mol Genet 1993;2:705-709
17. Simmons Z, Thornton CA, Seltzer WK, et al. Relative stability of a minimal CTG repeat expansion in a large kindred with myotonic dystrophy. Neurology 1998;50:1501-1504
18. Ashizawa T, Anvret M, Baiget M, et al. Characteristics of intergenerational contractions of the CTG repeat in myotonic dystrophy. Am J Hum Genet 1994;54:414-423
19. Wong LJ, Ashizawa T, Monckton DG, et al. Somatic heterogeneity of the CTG repeat in myotonic dystrophy is age and size dependent. Am J Hum Genet 1995;56:114-122
20. Martorell L, Monckton DG, Gamez J, et al. Progression of somatic CTG repeat length heterogeneity in the blood cells of myotonic dystrophy patients. Hum Mol Genet 1998;7:307-312
21. Zatz M, Passos-Bueno MR, Cerqueira A, et al. Analysis of the CTG repeat in skeletal muscle of young and adult myotonic dystrophy patients: When does the expansion occur? Hum Mol Genet 1995;4:401-406
22. Ashizawa T, Dubel JR, Harati Y. Somatic instability of CTG repeat in myotonic dystrophy. Neurology 1993;43:2674-2678
23. Thornton, CA, Johnson, K, Moxley, RT. Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes. Ann Neurol 35;1994:104-107
24. Kang S, Jaworski A, Ohshima K, et al. Expansion and deletion of CTG repeats from human disease genes are determined by the direction of replication in E. coli. Nature Genet 1995;10: 213-218
25. Gacy AM, Goellner G, Juranic N, et al. Trinucleotide repeats that expand in human disease form hairpin structures in vitro. Cell 1995;81:533-540
26. Wells RD. Molecular basis of genetic instability of triplet repeats. J Biol Chem 1996;271:2875-2878
27. Kunkel TA, Resnick MA, Gordenin DA. Mutator specificity and disease: Looking over the FENce. Cell 1997;88:155-158
28. Breschel TS, McInnis MG, Margolis RL, et al. A novel, heritable, expanding CTG repeat in an intron of the SEF2-1 gene on chromosome 18q21.1. Hum Mol Genet 1997;6:1855-1863
29. Monckton DG, Coolbaugh MI, Ashizawa KT, et al. Hypermutable myotonic dystrophy CTG repeats in transgenic mice. Nature Genet 1997;15:193-196
30. - conductance in resealed muscle fibre segments from patients with myotonic dystrophy. J Physiol 1990;425:391-405
31. + channels in myotonic dystrophy. Muscle Nerve 1994; 17:1264-1270
32. Fu YH, Friedman DL, Richards S, et al. Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. Science 1993;260:235-238
33. Shimokawa M, Ishiura S, Kameda N, et al. Novel isoform of myotonin protein kinase: Gene product of myotonic dystrophy is localized in the sarcoplasmic reticulum of skeletal muscle. Am J Pathol 1997;150:1285-1295
34. Jansen G, Groenen PJTA, Bachner D, et al. Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice. Nature Genet 1996;13:316-324
35. Reddy S, Smith DBJ, Rich MM, et al. Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nature Genet 1996;13:325-334
36. Wang YH, Amirhaeri S, Kang S, et al. Preferential nucleosome assembly at DNA triplet repeats from the myotonic dystrophy gene. Science 1994;265:669-671
37. Otten AD, Tapscott SJ. Triplet repeat expansion in myotonic dystrophy alters the adjacent chromatin structure. Proc Nat Acad Sei USA 1995;92:5465-5469
38. Klesert TR, Otten AD, Bird TD, et al. Trinucleotide repeat expan-sion at the myotonic dystrophy locus reduces expression of the DMAHP gene. Nature Genet 1997;16:402-406.
39. Thornton CA, Wymer JP, Simmons Z, et al. Expansion of the myotonic dystrophy CTG repeat reduces expression of the flanking DMAHP gene. Nature Genet 1997;16:407-409
40. Timchenko LT, Miller JW, Timchenko NAXDD, et al. Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res 1996;24:4407-4414
41. Dyken PR, Harper PS. Congenital dystrophia myotonica. Neurology 1973;23:465-473
42. de Die-Smulders CE, Howeler CJ, Thijs C, et al. Age and causes of death in adult-onset myotonic dystrophy. Brain 1998;121: 1557-1563
43. Delaporte C. Personality patterns in patients with myotonic dystrophy. Arch Neurol 1998;55:635-640
44. Palmer BW, Boone KB, Chang L, et al. Cognitive deficits and personality patterns in maternally versus paternally inherited myotonic dystrophy. J Clin Exp Neuropsychol 1994;16:784-795
45. Rubinsztein JS, Rubinsztein DC, Goodburn S, et al. Apathy and hypersomnia are common features of myotonic dystrophy. J Neurol Neurosurg Psychiatry 1998;64:510-515
46. Van Spaendonck KP, Ter Bruggen JP, Weyn BE, et al. Cognitive function in early adult and adult onset myotonic dystrophy. Acta Neurol Scand 1995;91:456-461
47. Tuikka RA, Laaksonen RK, Somer HV. Cognitive function in myotonic dystrophy: A follow-up study. Eur Neurol 1993;33:436-441
48. Rubinsztein JS, Rubinsztein DC, McKenna PJ, et al. Mild myotonic dystrophy is associated with memory impairment in the context of normal general intelligence. J Med Genet 1997; 34:229-233
49. Ono S, Kanda F, Takahashi K, et al. Neuronal cell loss in the dorsal raphe nucleus and the superior central nucleus in myotonic dystrophy: A clinicopathological correlation. Acta Neuropathol 1995;89:122-125
50. Ono S, Kanda F, Takahashi K, et al. Neuronal loss in the medullary reticular formation in myotonic dystrophy: A clinicopathological study. Neurology 1996;46:228-231
51. Culebras A, Feldman RG, Merk FB. Cytoplasmic inclusion bodies within neurons of the thalamus in myotonic dystrophy. A light and electron microscope study. J Neurol Sci 1973;19:319-329
52. Ono S, Takahashi K, Kanda F, et al. Immunohistochemical study of intracytoplasmic inclusion bodies of the thalamus in myotonic dystrophy. J Neurol Sci 1996;140:96-100
53. Huber SJ, Kissel JT, Shuttleworth EC, et al. Magnetic resonance imaging and clinical correlates of intellectual impairment in myotonic dystrophy. Arch Neurol 1989;46:536-540
54. Vermersch P, Sergeant N, Ruchoux MM, et al. Specific tau variants in the brains of patients with myotonic dystrophy. Neurology 1996;47:711-717
55. Chang L, Anderson T, Migneco OA, et al. Cerebral abnormalities in myotonic dystrophy. Cerebral blood flow, magnetic resonance imaging, and neuropsychological tests. Arch Neurol 1993;50:917-923
56. Harper PS: Myotonic dystrophy. London: WB Saunders, 1989
57. Fragola PV, Luzi M, Calo L, et al. Cardiac involvement in myotonic dystrophy. Am J Cardiol 1994;74:1070-1072
58. Tokgozoglu LS, Ashizawa T, Pacifico A. et al. Cardiac involvement in a large kindred with myotonic dystrophy. Quantitative assessment and relation to size of CTG repeat expansion. JAMA 1995;274:813-819
59. Harper PS. Congenital myatonic dystrophy in Britain. I. Clinical aspects. Arch Dis Child 1975;50:505-513
60. Reardon W, Newcombe R, Fenton I, et al. The natural history of congenital myotonic dystrophy: Mortality and long term clinical aspects. Arch Dis Child 1993;68:177-181
61. Joseph JT, Richards CS, Anthony DC, et al. Congenital myotonic dystrophy pathology and somatic mosaicism. Neurology 1997; 49:1457-1460
62. Sarnat HB, Silbert SW. Maturational arrest of fetal muscle in neonatal myotonic dystrophy. A pathologic study of four cases. Arch Neurol 1976;33:466-474
63. Farkas-Bargeton E, Barbet JP, Dancea S, et al. Immaturity of muscle fibers in the congenital form of myotonic dystrophy: Its consequences and its origin. J Neurol Sci 1988;83:145-159
64. Tsilfidis C, MacKenzie AE, Mettler G, et al. Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy. Nature Genet 1992;1: 192-195
65. Lavedan C, Hofmann-Radvanyi H, Rabes JP, et al. Different sex-dependent constraints in CTG length variation as explanation for congenital myotonic dystrophy. Lancet 1993;341: 237
66. Jansen G, Willems P, Coerwinkel M, et al. Gonosomal mosaicism in myotonic dystrophy patients: Involvement of mitotic events in (CTG)n repeat variation and selection against extreme expansion in sperm. Am J Hum Genet 1994;54:575-585
67. Griggs RC, Pandya S, Florence JM, et al. Randomized controlled trial of testosterone in myotonic dystrophy. Neurology 1989;39: 219-222
68. Thornton CA, Griggs RC, Welle S, et al. Recombinant human growth hormone treatment increases lean body mass in patients with myotonic dystrophy. Neurology 1993;43:A280
69. Vlachopapadopoulou E, Zachwieja JJ, Gertner JM, et al. Metabolic and clinical response to recombinant human insulin-like growth factor I in myotanic dystrophy - a clinical research center study. J Clin Endocrinol Metab 1995;80:3715-3723
70. Sugino M, Ohsawa N, Ito T, et al. A pilot study of dehydro-epiandrosterone sulfate in myotonic dystrophy. Neurology 1998;51:586-589
71. Gregoratos GMFC, Cheitlin MD, Conill A, et al. ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices. Circulation 1998;97:1325-1335
72. Ricker K, Koch MC, Lehmann-Horn F, et al. Proximal myotonic myopathy: A new dominant disorder with myotonia, muscle weakness, and cataracts. Neurology 1994;44:1448-1452
73. Thornton CA, Griggs RC, Moxley RT. Myotonic dystrophy with no trinucleotide repeat expansion. Ann Neurol 1994;35: 269-272
74. Meola G, Sansone V, Radice S, et al. A family with an unusual myotonic and myopathic phenotype and no CTG expansion (proximal myotonic myopathy syndrome): A challenge for future molecular studies. Neuromusc Disord 1996;6:143-150
75. Ricker K, Koch MC, Lehmann-Horn F, et al. Proximal myotonic myopathy. Clinical features of a multisystem disorder similar to myotonic dystrophy. Arch Neurology 1995;52:25-31
76. Udd B, Krahe R, Wallgrenpettersson C, et al. Proximal myotonic dystrophy - a family with autosomal dominant muscular dystrophy, cataracts, hearing loss, and hypogonadism - heterogeneity of proximal myotonic syndromes. Neuromusc Disord 1997: 7:217-228
77. Abbruzzese C, Krahe R, Liguori M, et al. Myotonic dystrophy phenotype without expansion of (CTG)n repeat: An entity distinct from proximal myotonic myopathy (PROMM)? J Neurol 1996;243:715-721
78. Day JW, Roelofs R, Leroy B, et al. Clinical and genetic characterization of a five-generation family with a novel form of myotonic dystrophy (DM2). Neuromusc Disord 1999;9:19-27
79. Hund E, Jansen O, Koch MC, et al. Proximal myotonic myopathy with MRI white matter abnormalities of the brain. Neurology 1997;48:33-37
80. Ranum LP, Rasmussen PF, Benzow KA, et al. Genetic mapping of a second myotonic dystrophy locus. Nature Genet 1998;19: 196-198
81. Ricker K, Grimm T, Koch MC, et al. Linkage to chromosome 3q in proximal myotonic myopathy (PROMM). Neurology 1999;52:170-171